Methylation of the MGMT (O6‐Methylguanine‐DNA‐methyltransferase) promoter reduces MGMT expression, making tumor cells dysregulated in the repair mechanism of drug‐induced DNA damage and more sensitive to chemotherapeutic drugs [13]. Here, MGMT is linked to neoplasm.